{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-25-000010","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.238981+00:00","generated_at":"2026-05-27T03:30:34.250385+00:00","sec_items":["1.01","5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evolent Health enters cooperation with Engaged Capital, appoints Springstubb to board","bullets":["Appointed Brendan Springstubb (Engaged Capital affiliate) to Board; he joins Strategy Committee.","Engaged Capital bound by standstill: cannot exceed 9.9% ownership or launch proxy contests.","M. Bridget Duffy resigned from Board effective Feb 3, 2025, not due to any disagreement.","Richard Jelinek to be named Chair of the Board at 2025 Annual Meeting, succeeding Cheryl Scott.","Board continues independent director search; five new independent directors added in three years."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-25-000010","json":"https://secwatch.observer/filing/0001628908-25-000010.json","markdown":"https://secwatch.observer/filing/0001628908-25-000010.md","text":"https://secwatch.observer/filing/0001628908-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000010/0001628908-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000010/evh-20250203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:30:34.250385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"844ea963cf","claim":"M. Bridget Duffy resigned as Director at Evolent Health, Inc..","evidence_excerpt":"On February 3, 2025, M. Bridget Duffy, MD resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000010/0001628908-25-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d162a2fafe","claim":"Brendan Springstubb was appointed as Director at Evolent Health, Inc..","evidence_excerpt":"On February 4, 2025, the Board (1) appointed Mr. Springstubb as a director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000010/0001628908-25-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}